The content is available as a PDF (121.7 KB).
. 2021 Jun 11;20:S57. doi: 10.1016/S1569-1993(21)01089-4
P062 Impact of the SARS-CoV-2 pandemic on clinical trials in the ECFS-CTN during 2020
S Van Koningsbruggen-Rietschel
, V Bulteel
, F Dunlevy
, K Hayes
, A Verbrugge
, D Downey
; ECFS-CTN study group
S Van Koningsbruggen-Rietschel
Find articles by S Van Koningsbruggen-Rietschel
V Bulteel
Find articles by V Bulteel
F Dunlevy
Find articles by F Dunlevy
K Hayes
Find articles by K Hayes
A Verbrugge
Find articles by A Verbrugge
D Downey
Find articles by D Downey
Issue date 2021.
Copyright © 2021 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC8192166